日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Neo-adjuvant pembrolizumab in stage IV high-grade serous ovarian cancer: the phase II Neo-Pembro trial

新辅助帕博利珠单抗治疗IV期高级别浆液性卵巢癌:II期Neo-Pembro试验

S L Aronson ,B Thijssen ,M Lopez-Yurda ,S N Koole ,P van der Leest ,A León-Castillo ,R Harkes ,I M Seignette ,J Sanders ,M Alkemade ,I Kemper ,M J Holtkamp ,I A M Mandjes ,A Broeks ,M J Lahaye ,M A Rijlaarsdam ,D van den Broek ,L F A Wessels ,H M Horlings ,W J van Driel ,G S Sonke

Histopathological response to chemotherapy and survival of mucinous type gastric cancer

黏液性胃癌化疗的组织病理学反应和生存率

Caspers, Irene A; Slagter, Astrid E; Vissers, Pauline A J; Lopez-Yurda, Martha; Beerepoot, Laurens V; Ruurda, Jelle P; Nieuwenhuijzen, Grard A P; Gisbertz, Suzanne S; van Berge Henegouwen, Mark I; Hartgrink, Henk H; Goudkade, Danny; Kodach, Liudmila L; van Sandick, Johanna W; Verheij, Marcel; Verhoeven, Rob H A; Cats, Annemieke; van Grieken, Nicole C T

Evaluating the Efficacy of Various Deep Learning Architectures for Automated Preprocessing and Identification of Impacted Maxillary Canines in Panoramic Radiographs

评估各种深度学习架构在全景X光片中自动预处理和识别阻生上颌尖牙方面的有效性

Alenezi, Othman; Bhattacharjee, Tanmoy; Alseed, Hasna Ahmad; Tosun, Yurda Isik; Chaudhry, Jahanzeb; Prasad, Sabarinath

Metabolic parameters on baseline and early [(18)F]FDG PET/CT as a predictive biomarker for resistance to BRAF/MEK inhibition in advanced cutaneous BRAFV600-mutated melanoma

基线和早期[(18)F]FDG PET/CT代谢参数作为晚期皮肤BRAFV600突变黑色素瘤对BRAF/MEK抑制剂耐药性的预测性生物标志物

van der Hiel, Bernies; de Wit-van der Veen, Berlinda J; van den Eertwegh, Alfons J M; Vogel, Wouter V; Stokkel, Marcel P M; Lopez-Yurda, Marta; Boellaard, Ronald; Kapiteijn, Ellen W; Hospers, Geke A P; Aarts, Maureen J B; de Vos, Filip Y F L; Boers-Sonderen, Marye J; van der Veldt, Astrid A M; de Groot, Jan Willem B; Haanen, John B A G

Potentially Overlooked Risk for Neuropsychiatric Symptoms in Children: Montelukast Treatment

孟鲁司特治疗可能导致儿童神经精神症状,但这一风险可能被忽视。

Tunca, Seda; Yilmaz, Ozge; Ocalan, Merve; Arga, Mustafa; Cavkaytar, Ozlem; Ozceker, Deniz; Kiliç, Mehmet; Duksal, Fatma; Can, Demet; Sancakli, Ozlem; Kaya, Mehmet Şirin; Ercan, Nazli; Gunaydin, Nursen Cigerci; Aydogan, Metin; Demir, Esen; Sancak, Recep; Karadag, Sefika İlknur Kökcü; Sapan, Nihat; Demir, Ahmet Ugur; Bilac, Oznur; Misirlioglu, Emine Dibek; Turkeli, Ahmet; Artac, Hasibe; Gungor, Hatice Eke; Cokugras, Haluk; Orhan, Fazil; Bingol, Aysen; Uysal, Pinar; Keles, Sennur; Ozhan, Aylin Kont; Tuncel, Tuba; Keskin, Ozlem; Arik, Elif; Özdemir, Öner; Can, Ceren; Altinel, Nazan; Harmanci, Koray; Simsek, Yurda; Altintas, Derya Ufuk; Ozmen, Serap; Uzuner, Nevin; Canıtez, Yakup; Yüksel, Hasan

Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

早期三阴性乳腺癌新辅助治疗:纳武利尤单抗或纳武利尤单抗联合伊匹木单抗:一项 II 期适应性试验

Iris Nederlof # ,Olga I Isaeva # ,Manon de Graaf ,Robbert C A M Gielen ,Noor A M Bakker ,Adrianne L Rolfes ,Hannah Garner ,Bram Boeckx ,Joleen J H Traets ,Ingrid A M Mandjes ,Michiel de Maaker ,Thomas van Brussel ,Maksim Chelushkin ,Elisa Champanhet ,Marta Lopez-Yurda ,Koen van de Vijver ,José G van den Berg ,Ingrid Hofland ,Natasja Klioueva ,Ritse M Mann ,Claudette E Loo ,Frederieke H van Duijnhoven ,Victoria Skinner ,Sylvia Luykx ,Emile Kerver ,Ekaterina Kalashnikova ,Marloes G J van Dongen ,Gabe S Sonke ,Sabine C Linn ,Christian U Blank ,Karin E de Visser ,Roberto Salgado ,Lodewyk F A Wessels ,Caroline A Drukker ,Ton N Schumacher ,Hugo M Horlings ,Diether Lambrechts ,Marleen Kok

Gastric and duodenal cancer in individuals with Lynch syndrome: a nationwide cohort study

林奇综合征患者的胃癌和十二指肠癌:一项全国性队列研究

Caspers, Irene A; Eikenboom, Ellis L; Lopez-Yurda, Marta; van Grieken, Nicole C T; Bisseling, Tanya M; Dekker, Evelien; Bastiaansen, Barbara A J; Cats, Annemieke; van Leerdam, Monique E

Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1)

肿瘤微环境特征分析用于对高级别浆液性卵巢癌患者进行腹腔热灌注化疗分层(OVHIPEC-1)

Aronson, S Lot; Walker, Cédric; Thijssen, Bram; van de Vijver, Koen K; Horlings, Hugo M; Sanders, Joyce; Alkemade, Maartje; Koole, Simone N; Lopez-Yurda, Marta; Lok, Christianne A R; Rottenberg, Sven; van Rheenen, Jacco; Sonke, Gabe S; van Driel, Willemien J; Kester, Lennart A; Hahn, Kerstin

IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma

IFN-γ 特征可用于选择 III 期黑色素瘤患者的新辅助治疗方案

Irene L M Reijers # ,Disha Rao # ,Judith M Versluis ,Alexander M Menzies ,Petros Dimitriadis ,Michel W Wouters ,Andrew J Spillane ,Willem M C Klop ,Annegien Broeks ,Linda J W Bosch ,Marta Lopez-Yurda ,Winan J van Houdt ,Robert V Rawson ,Lindsay G Grijpink-Ongering ,Maria Gonzalez ,Sten Cornelissen ,Jasper Bouwman ,Joyce Sanders ,Elsemieke Plasmeijer ,Yannick S Elshot ,Richard A Scolyer ,Bart A van de Wiel ,Daniel S Peeper ,Alexander C J van Akkooi ,Georgina V Long ,Christian U Blank

IMPemBra: a phase 2 study comparing pembrolizumab with intermittent/short-term dual MAPK pathway inhibition plus pembrolizumab in patients with melanoma harboring the BRAFV600 mutation

IMPemBra:一项 2 期研究,比较帕博利珠单抗与间歇性/短期双重 MAPK 通路抑制联合帕博利珠单抗治疗携带 BRAFV600 突变的黑色素瘤患者的效果

Elisa A Rozeman, Judith M Versluis, Karolina Sikorska, Esmée P Hoefsmit, Petros Dimitriadis, Disha Rao, Ruben Lacroix, Lindsay G Grijpink-Ongering, Marta Lopez-Yurda, Birthe C Heeres, Bart A van de Wiel, Claudie Flohil, Aysegul Sari, Stijn W T P J Heijmink, Daan van den Broek, Annegien Broeks, Jan W